CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease

Chronic antigenic stimulation leads to gradual accumulation of late‐differentiated, antigen‐specific, oligoclonal T cells, particularly within the CD8+ T‐cell compartment. They are characterized by critically shortened telomeres, loss of CD28 and/or gain of CD57 expression and are defined as either CD8+CD28− or CD8+CD57+ T lymphocytes. There is growing evidence that the CD8+CD28− (CD8+CD57+) T‐cell population plays a significant role in various diseases or conditions, associated with chronic immune activation such as cancer, chronic intracellular infections, chronic alcoholism, some chronic pulmonary diseases, autoimmune diseases, allogeneic transplantation, as well as has a great influence on age‐related changes in the immune system status. CD8+CD28− (CD8+CD57+) T‐cell population is heterogeneous and composed of various functionally competing (cytotoxic and immunosuppressive) subsets thus the overall effect of CD8+CD28− (CD8+CD57+) T‐cell‐mediated immunity depends on the predominance of a particular subset. Many articles claim that CD8+CD28− (CD8+CD57+) T cells have lost their proliferative capacity during process of replicative senescence triggered by repeated antigenic stimulation. However recent data indicate that CD8+CD28− (CD8+CD57+) T cells can transiently up‐regulate telomerase activity and proliferate under certain stimulation conditions. Similarly, conflicting data is provided regarding CD8+CD28− (CD8+CD57+) T‐cell sensitivity to apoptosis, finally leading to the conclusion that this T‐cell population is also heterogeneous in terms of its apoptotic potential. This review provides a comprehensive approach to the CD8+CD28− (CD8+CD57+) T‐cell population: we describe in detail its origins, molecular and functional characteristics, subsets, role in various diseases or conditions, associated with persistent antigenic stimulation.

[1]  Michael J. Bevan,et al.  CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.

[2]  D. Unutmaz,et al.  Revisiting Immune Exhaustion During HIV Infection , 2011, Current HIV/AIDS reports.

[3]  J. Campisi,et al.  Four faces of cellular senescence , 2011, The Journal of cell biology.

[4]  A. Torkamani,et al.  Gene profile analysis of CD8(+) ILT3-Fc induced T suppressor cells. , 2011, Human immunology.

[5]  Rita B. Effros,et al.  Telomere/telomerase dynamics within the human immune system: Effect of chronic infection and stress , 2011, Experimental Gerontology.

[6]  N. Dobrovolskienė,et al.  Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. , 2011, Anticancer research.

[7]  A. Sharrett,et al.  T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women , 2011, The Journal of infectious diseases.

[8]  Yan Zhang,et al.  Human cytomegalovirus‐specific CD8+ T‐cell expansions contain long‐lived cells that retain functional capacity in both young and elderly subjects , 2011, Immunology.

[9]  Richard J Simpson,et al.  Aging, Persistent Viral Infections, and Immunosenescence: Can Exercise "Make Space"? , 2011, Exercise and sport sciences reviews.

[10]  A. Salminen,et al.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process , 2011, Cellular and Molecular Life Sciences.

[11]  M. Drayson,et al.  Latent Cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise , 2010, Brain, Behavior, and Immunity.

[12]  P. Espinosa-Cueto,et al.  Decreased Expression of T-Cell Costimulatory Molecule CD28 on CD4 and CD8 T Cells of Mexican Patients with Pulmonary Tuberculosis , 2010, Tuberculosis research and treatment.

[13]  D. Characiejus,et al.  “First do no harm” and the importance of prediction in oncology , 2010, EPMA Journal.

[14]  J. Olloquequi,et al.  Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients , 2010, European Respiratory Journal.

[15]  Y. Koide,et al.  Induction of Specific CD8+ T Cells against Intracellular Bacteria by CD8+ T-Cell-Oriented Immunization Approaches , 2010, Journal of biomedicine & biotechnology.

[16]  A. Doseff,et al.  The Small Heat Shock Protein 27 Is a Key Regulator of CD8+CD57+ Lymphocyte Survival , 2010, The Journal of Immunology.

[17]  P. Airó,et al.  Decreased Circulating CD28-negative T Cells in Patients with Rheumatoid Arthritis Treated with Abatacept Are Correlated with Clinical Response , 2010, The Journal of Rheumatology.

[18]  D. Focosi,et al.  CD57+ T lymphocytes and functional immune deficiency , 2010, Journal of leukocyte biology.

[19]  J. Michálek,et al.  Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis. , 2010, Cellular immunology.

[20]  Richard J Simpson,et al.  Senescent phenotypes and telomere lengths of peripheral blood T-cells mobilized by acute exercise in humans. , 2010, Exercise immunology review.

[21]  S. Wenzel.  Eosinophils in asthma--closing the loop or opening the door? , 2009, The New England journal of medicine.

[22]  D. Price,et al.  The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor. , 2009, Blood.

[23]  W. Parson,et al.  CD28(-)CD8(+) T cells do not contain unique clonotypes and are therefore dispensable. , 2009, Immunology letters.

[24]  Antonio Polley,et al.  Tissue-Specific Differences in PD-1 and PD-L1 Expression during Chronic Viral Infection: Implications for CD8 T-Cell Exhaustion , 2009, Journal of Virology.

[25]  Gulshan Sharma,et al.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. , 2009, Proceedings of the American Thoracic Society.

[26]  K. Malmberg,et al.  T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells1 , 2009, The Journal of Immunology.

[27]  A. Galar,et al.  Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis , 2009, Advances in hematology.

[28]  K. Kuliczkowski,et al.  Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas. , 2009, Postepy higieny i medycyny doswiadczalnej.

[29]  N. Weng,et al.  CD28(-) T cells: their role in the age-associated decline of immune function. , 2009, Trends in immunology.

[30]  S. J. Griffiths,et al.  KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. , 2009, Blood.

[31]  T. Maurer,et al.  CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV , 2009, Infectious Agents and Cancer.

[32]  Lan Wang,et al.  Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

[33]  Liyong Pu,et al.  CD8(+)CD103(+) regulatory T cells in spontaneous tolerance of liver allografts. , 2009, International immunopharmacology.

[34]  D. Mancini,et al.  Ig-Like Transcript 3 Regulates Expression of Proinflammatory Cytokines and Migration of Activated T Cells1 , 2009, The Journal of Immunology.

[35]  P. Katsikis,et al.  Memory T cells need CD28 costimulation to remember. , 2009, Seminars in immunology.

[36]  R. Detels,et al.  Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression , 2009, Journal of acquired immune deficiency syndromes.

[37]  M. Betts,et al.  The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression , 2008, Journal of leukocyte biology.

[38]  A. Doseff,et al.  Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. , 2009, Frontiers in bioscience.

[39]  Lutfan Lazuardi,et al.  Microarray analysis reveals similarity between CD8+CD28− T cells from young and elderly persons, but not of CD8+CD28+ T cells , 2009, Biogerontology.

[40]  A. Seltsam,et al.  Permanent silencing of NKG2A expression for cell-based therapeutics , 2009, Journal of Molecular Medicine.

[41]  N. Chaput,et al.  Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue , 2008, Gut.

[42]  G. Vlad,et al.  CD8+ T suppressor cells and the ILT3 master switch. , 2008, Human immunology.

[43]  L. Chess,et al.  Qa-1/HLA-E-restricted regulatory CD8+ T cells and self-nonself discrimination: an essay on peripheral T-cell regulation. , 2008, Human immunology.

[44]  D. Olive,et al.  Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells. , 2008, Human immunology.

[45]  I. T. Ten Berge,et al.  Alloantigen-induced regulatory CD8+CD103+ T cells. , 2008, Human immunology.

[46]  O. Majdic,et al.  The capacity of the TNF family members 4‐1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells , 2008, European journal of immunology.

[47]  C. Pannuti,et al.  Impact of Cytomegalovirus and Grafts versus Host Disease on the Dynamics of CD57+CD28−CD8+ T Cells After Bone Marrow Transplant , 2008, Clinics.

[48]  Xue-guang Zhang,et al.  Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells , 2008, Journal of Clinical Immunology.

[49]  H. Direskeneli,et al.  CD8+CD28−, suppressive T cells in systemic lupus erythematosus , 2008, Lupus.

[50]  F. Chiodi,et al.  Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription , 2008, AIDS.

[51]  P. Tomasec,et al.  Proliferation and interleukin 5 production by CD8hiCD57+ T cells , 2008, European journal of immunology.

[52]  E. Aleknavičius,et al.  Peripheral blood CD8highCD57+ lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-alpha. , 2008, Anticancer research.

[53]  Lloyd J. Old,et al.  CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer , 2007, Clinical Cancer Research.

[54]  M. Sela,et al.  The role of CD8+CD28− regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand , 2007, Proceedings of the National Academy of Sciences.

[55]  D. Olive,et al.  CD8+CD28− T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers1 , 2007, The Journal of Immunology.

[56]  G. Freeman,et al.  PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status , 2007, AIDS.

[57]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[58]  R. Cortesini,et al.  Central role of ILT3 in the T suppressor cell cascade. , 2007, Cellular immunology.

[59]  A. Lawson,et al.  The Loss of Telomerase Activity in Highly Differentiated CD8+CD28−CD27− T Cells Is Associated with Decreased Akt (Ser473) Phosphorylation1 , 2007, The Journal of Immunology.

[60]  R. Lascuraín,et al.  Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells , 2007, British Journal of Ophthalmology.

[61]  D. Focosi,et al.  CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  G. Freeman,et al.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection , 2007, Nature Immunology.

[63]  J. V. van Meerwijk,et al.  CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. , 2006, Gastroenterology.

[64]  N. Weng,et al.  Generation and Growth of CD28nullCD8+ Memory T Cells Mediated by IL-15 and Its Induced Cytokines1 , 2006, The Journal of Immunology.

[65]  E. Zenteno,et al.  Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis. , 2006, Clinical immunology.

[66]  Denis Puthier,et al.  High Cytotoxic and Specific Migratory Potencies of Senescent CD8+CD57+ Cells in HIV-Infected and Uninfected Individuals1 , 2006, The Journal of Immunology.

[67]  M. Nikolova,et al.  Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients. , 2006, World journal of gastroenterology.

[68]  E. Shevach.  From vanilla to 28 flavors: multiple varieties of T regulatory cells. , 2006, Immunity.

[69]  J. Dahlstrom,et al.  CD8 T cells expressing killer Ig‐like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood , 2006, Journal of leukocyte biology.

[70]  Karnail Singh,et al.  Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. , 2006, Blood.

[71]  Anthony M. Byers,et al.  CD94/NKG2A Expression Is Associated with Proliferative Potential of CD8 T Cells during Persistent Polyoma Virus Infection1 , 2006, The Journal of Immunology.

[72]  A. Fietta,et al.  Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. , 2006, Human immunology.

[73]  S. Shahgasempour,et al.  Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients. , 2006, Archives of Iranian medicine.

[74]  K. Wood,et al.  Apoptosis of CD57+ and CD57- lymphocytes in the lung and blood of HIV-infected subjects. , 2005, Clinical immunology.

[75]  P. Klenerman,et al.  Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection , 2005, PLoS medicine.

[76]  A. Hamzaoui,et al.  Inflammatory Process of CD8+CD28− T Cells in Induced Sputum From Asthmatic Patients , 2005, Mediators of inflammation.

[77]  A. Vallejo,et al.  Diversity of NKR expression in aging T cells and in T cells of the aged: The new frontier into the exploration of protective immunity in the elderly , 2005, Experimental Gerontology.

[78]  T. Curiel,et al.  Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. , 2005, Cancer research.

[79]  A. Vallejo,et al.  CD28 extinction in human T cells: altered functions and the program of T‐cell senescence , 2005, Immunological reviews.

[80]  G. Vlad,et al.  License to Heal: Bidirectional Interaction of Antigen-Specific Regulatory T Cells and Tolerogenic APC , 2005, The Journal of Immunology.

[81]  A. Kourtis,et al.  Expression of Killer Cell Lectin-Like Receptor G1 on Antigen-Specific Human CD8+ T Lymphocytes during Active, Latent, and Resolved Infection and its Relation with CD57 , 2005, The Journal of Immunology.

[82]  R. Solana,et al.  CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype , 2005, Cancer Immunology, Immunotherapy.

[83]  G. Pawelec,et al.  An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[84]  S. Jackson,et al.  Human cell senescence as a DNA damage response , 2005, Mechanisms of Ageing and Development.

[85]  A. Órfão,et al.  Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution , 1993, Annals of Hematology.

[86]  S. Kim-Schulze,et al.  Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. , 2005, International immunopharmacology.

[87]  T. Curiel,et al.  Plasmacytoid Dendritic Cells Induce CD 8 + Regulatory T Cells In Human Ovarian Carcinoma , 2005 .

[88]  J. Dambrosia,et al.  Elevated pro-inflammatory CD4+CD28− lymphocytes and stroke recurrence and death , 2004, Neurology.

[89]  S. Negrini,et al.  Non-antigen specific CD8+ T suppressor lymphocytes , 2004, Clinical and Experimental Medicine.

[90]  G. Roué,et al.  A Dual Role of IFN-α in the Balance between Proliferation and Death of Human CD4+ T Lymphocytes during Primary Response1 , 2004, The Journal of Immunology.

[91]  Victor Appay,et al.  Lessons from the study of T-cell differentiation in persistent human virus infection. , 2004, Seminars in immunology.

[92]  R. Solana,et al.  Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword? , 2004, Cancer Immunology, Immunotherapy.

[93]  L. Chess,et al.  Resurrecting CD8+ suppressor T cells , 2004, Nature Immunology.

[94]  B. Boehm,et al.  Oligoclonal CD8+ T-Cell Expansion in Patients with Chronic Hepatitis C Is Associated with Liver Pathology and Poor Response to Interferon-α Therapy , 2004, Journal of Clinical Immunology.

[95]  R. Effros.  Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy , 2004, Cancer Immunology, Immunotherapy.

[96]  Eric Vivier,et al.  Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future , 2004, Nature Reviews Immunology.

[97]  Tao Dong,et al.  Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.

[98]  M. Troye-Blomberg,et al.  Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination. , 2004, Journal of clinical & laboratory immunology.

[99]  T. Mueller,et al.  Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion , 2003, Transplantation.

[100]  G. Freeman,et al.  Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses , 2003, European journal of immunology.

[101]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[102]  K. Debatin,et al.  Constitutive Caspase Activation and Impaired Death-Inducing Signaling Complex Formation in CD95-Resistant, Long-Term Activated, Antigen-Specific T Cells , 2003, The Journal of Immunology.

[103]  K. Pfeiffer,et al.  Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis , 2003, Arthritis research & therapy.

[104]  T. Whiteside,et al.  Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer , 2003, Cancer Immunology, Immunotherapy.

[105]  Nitin J. Karandikar,et al.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. , 2003, Blood.

[106]  R. Effros,et al.  Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. , 2002, Clinical immunology.

[107]  D. Characiejus,et al.  Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. , 2002, Anticancer research.

[108]  N. Suciu-Foca,et al.  CD8+ T suppressor cells are back to the game: are they players in autoimmunity? , 2002, Autoimmunity reviews.

[109]  Richard A. Miller,et al.  A subset of CD8 memory T cells from old mice have high levels of CD28 and produce IFN-gamma. , 2002, Clinical immunology.

[110]  M. Salmon,et al.  Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. , 2002, Blood.

[111]  D. Richman,et al.  Dynamics of T Cell Responses in HIV Infection , 2002, The Journal of Immunology.

[112]  Walther Parson,et al.  Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1 , 2002, The Journal of Immunology.

[113]  G. Freeman,et al.  PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2 , 2002, European journal of immunology.

[114]  Fernando A Arosa,et al.  CD8+CD28– T cells: Certainties and uncertainties of a prevalent human T‐cell subset , 2002, Immunology and cell biology.

[115]  A. Bernard,et al.  THE TWO-SIGNAL MODEL OF T-CELL ACTIVATION AFTER 30 YEARS , 2002, Transplantation.

[116]  K. Pfeiffer,et al.  Circulating cytotoxic CD8+ CD28- T cells in ankylosing spondylitis , 2001, Arthritis research.

[117]  Susan M. Kaech,et al.  Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .

[118]  D. Margulies,et al.  Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.

[119]  R. Stricker,et al.  Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. , 2002, Annals of agricultural and environmental medicine : AAEM.

[120]  F. Sigaux,et al.  Oligoclonal Expansion of CD 8 + CD 57 + T Cells With Restricted T-cell Receptor / 3 Chain Variability After Bone Marrow Transplantation , 2002 .

[121]  W. O'Fallon,et al.  Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals , 2001, Journal of Virology.

[122]  N. Young,et al.  Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. , 2001, Experimental hematology.

[123]  A. Basten,et al.  Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. , 2001, Blood.

[124]  E. Eylar,et al.  HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset , 2001, BMC Immunology.

[125]  Lyell Brougham,et al.  Make space for it , 2001 .

[126]  R. A. Coleman,et al.  TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease. , 2001, Alcohol.

[127]  S. Seki,et al.  Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells , 2001, Immunology.

[128]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[129]  R. Ciubotariu,et al.  CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population. , 2001, Transplantation proceedings.

[130]  T. Kivelä,et al.  The HNK-1 Carbohydrate Epitope in the Eye: Basic Science and Functional Implications , 2001, Progress in Retinal and Eye Research.

[131]  R. Solana,et al.  Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells , 2001, Mechanisms of Ageing and Development.

[132]  E. Bandrés,et al.  The Increase of IFN-γ Production through Aging Correlates with the Expanded CD8+highCD28−CD57+ Subpopulation , 2000 .

[133]  M. Salmon,et al.  Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. , 2000, International immunology.

[134]  E. Bandrés,et al.  The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. , 2000, Clinical immunology.

[135]  M. Weekes,et al.  Large clonal expansions of human virus‐specific memory cytotoxic T lymphocytes within the CD57+ CD28– CD8+ T‐cell population , 1999, Immunology.

[136]  E. Leteurtre,et al.  Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression. , 1999, International immunology.

[137]  R. Effros,et al.  Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation☆ , 1999, Experimental Gerontology.

[138]  E. Garrafa,et al.  Generation of CD28− cells from long‐term‐stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28− T cells in HIV‐1‐infected patients , 1999, Journal of leukocyte biology.

[139]  J. Hughes,et al.  First Do No Harm: Adverse Effects of Grouping Deviant Youth for Skills Training , 1999 .

[140]  A. Falsey,et al.  Role of cytomegalovirus in the T cell changes seen in elderly individuals. , 1999, Clinical immunology.

[141]  E. Vicaut,et al.  CD28 Expression in T Cell Aging and Human Longevity , 1998, Experimental Gerontology.

[142]  Merino,et al.  Progressive decrease of CD8high+ CD28+ CD57− cells with ageing , 1998, Clinical and experimental immunology.

[143]  Frassanito,et al.  CD8+/CD57+ cells and apoptosis suppress T‐cell functions in multiple myeloma , 1998, British journal of haematology.

[144]  V. Calvez,et al.  CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. , 1998, International immunology.

[145]  P. Gregersen,et al.  Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. , 1997, Journal of immunology.

[146]  P. Lehner,et al.  CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[147]  C. Franceschi,et al.  Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians , 1996, Immunology.

[148]  D. Olive,et al.  Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity , 1996, Journal of virology.

[149]  K. Hatakeyama,et al.  Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer , 1995, Clinical and experimental immunology.

[150]  F. Preijers,et al.  Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection , 1995, British journal of haematology.

[151]  R. Effros,et al.  Decline in CD28+ T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence , 1994, Experimental Gerontology.

[152]  B. Autran,et al.  An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients , 1994, European journal of immunology.

[153]  A. Landay,et al.  A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. , 1994, Clinical immunology and immunopathology.

[154]  C. Noel,et al.  CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57− subset and its progressive replacement by CD8+CD57+ T cells , 1994, Clinical and experimental immunology.

[155]  F. Sigaux,et al.  Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. , 1994, Blood.

[156]  J. E. West.  First, do no harm. , 1994, Alabama medicine : journal of the Medical Association of the State of Alabama.

[157]  L. Borysiewicz,et al.  Subsets of CD8 +, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses , 1993, Clinical and experimental immunology.

[158]  B. Autran,et al.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. , 1989, Journal of immunology.

[159]  A. De Gasperis.  [Pleural mesothelioma]. , 1950, L' Ospedale maggiore.